
Organometallics p. 3958 - 3962 (1995)
Update date:2022-07-30
Topics: Characterization Isolation and Purification Preparation of the starting material
Liu, Ling-Kang
Eke, Uche B.
Adediran Mesubi
One equivalent of NaOMe is added to an equimolar mixture of (η-C5H5)Fe(CO)2I (1) and PPh3 after the addition of a few drops of n-BuLi, to take advantage of the catalytic formation of [(η5-C5H5)Fe(CO)2(PPh) 3]+I- (3), which, upon formation, becomes the virtual reactant with OMe-. The OMe- reaction yields the methyl carboxylate (η5-C5H5)Fe(CO)(PPh)3C(O)OMe (8Me). A similar pattern is observed in the OPh-, SMe-, and SPh- reactions, resulting in the derivatives (η5-C5H5)Fe(CO)(PPh)3C(O)OPh (8Ph), (η5-C5H5)Fe(CO)(PPh)3C(O)SMe (9Me), and (η5-C5H5)Fe(CO)(PPh)3C(O)SPh (9Ph), respectively. The metalloesters exist simultaneously in the molecular form (8R) and the ionic form [(η5-C5H5)Fe(CO)2(PPh) 3]+ OR- (10R; R = Me, Ph) in solutions of medium polarity (CHCl3, CH2Cl2, and MeCN), whereas the S analogs exist only in the ionic form. In CHCl3, CH2Cl2, and MeCN solutions, the ratio of neutral 8Me to ionic 10Me is ca. (6.0-8.4):1, as judged from the NMR measurements. Nonetheless, the ratio of neutral 8Ph to ionic 10Ph is ca. (0.17-0.25):1.
website:http://www.sigmaaldrich.com
Contact:800 558-9160
Address:Industriestrasse 25CH-9471 Buchs SGSwitzerland
BrightGene Bio-Medical Technology Co., Ltd.
website:https://en.bright-gene.com/
Contact:+86-512-62551801
Address:Building C25 - C31, No. 218 Xinghu Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.
Contact:86 21 3772 9386
Address:Rm.1803,Starry Bldg.1,1505 Meijiabang Road,Shanghai 201620 China
Shanghai Rainbow Chemistry Co., Ltd.
Contact:+86-21-64968086-5815/5812
Address:3rd floor, Building 7, 251 Faladi Road, Zhangjiang Hi-Tech Park, Pudong District, Shanghai, P.R. China
ZhangJiaGang YaRui Chemical Co.,Ltd.
Contact:0512-58360968
Address:China JiangSu Province Zhang Jia Gang City YangShe Oriental Plaza Building 10 B307
Doi:10.1016/0040-4039(94)85340-1
(1994)Doi:10.1080/15257779508012498
(1995)Doi:10.1080/00397919508011814
(1995)Doi:10.1021/acschemneuro.8b00196
(2019)Doi:10.1021/j150666a041
(1984)Doi:10.1016/0008-6215(94)00004-Y
(1995)